Bio-Rad Laboratories (BIO) Net Income towards Common Stockholders (QoQ) (2009 - 2026)
Bio-Rad Laboratories (BIO) Net Income towards Common Stockholders (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 170.46% |
| Mar 31, 2026 | -173.21% |
| Dec 31, 2025 | 310.59% |
| Sep 30, 2025 | -207.58% |
| Jun 30, 2025 | 396.56% |
| Mar 31, 2025 | 108.94% |
| Dec 31, 2024 | -209.58% |
| Sep 30, 2024 | 130.16% |
| Jun 30, 2024 | -664.08% |
| Mar 31, 2024 | 9.77% |
| Dec 31, 2023 | 229.14% |
| Sep 30, 2023 | 109.14% |
| Jun 30, 2023 | -1,785.31% |
| Mar 31, 2023 | -91.67% |
| Dec 31, 2022 | 608.46% |
| Sep 30, 2022 | 82.40% |
| Jun 30, 2022 | 72.53% |
| Mar 31, 2022 | -115.13% |
| Dec 31, 2021 | -139.85% |
| Sep 30, 2021 | 329.69% |